Literature DB >> 33508753

Contingent Valuation: A Pilot Study for Eliciting Willingness to Pay for a Reduction in Mortality From Vaccine-Preventable Illnesses for Children and Adults in Bangladesh.

Deborah Odihi1, Gatien De Broucker2, Zahid Hasan3, Sayem Ahmed3, Dagna Constenla4, Jasim Uddin3, Bryan Patenaude2.   

Abstract

OBJECTIVES: The contingent valuation (CV) method elicits WTP for calculating the value of statistical life (VSL). CV approaches for assessing VSL are uncommon in many low and middle-income countries (LMICs). Between 2008 and 2018 only 44 articles utilized WTP in a health-related field and of these only 5 (11%) utilized CV to assess the WTP for a mortality risk reduction. We elicit WTP estimates and compute VSL using the CV method in Bangladesh.
METHODS: The pilot study was primarily aimed at developing best practice guidelines for CV studies in LMICs to get more robust WTP estimates. To this end, we explored three methodological a) Varying the name of the intervention, keeping all other characteristics constant; b) varying the effectiveness of the health intervention and c) offering an overnight period to think about the WTP scenario. The survey was administered 413 randomly selected participants. VSL was for a 1/3000 mortality risk reduction.
RESULTS: We had more males (54%) than females (46%) and the mean annual self-reported income was $5,683.36. Mean VSL is $11,339.70 with a median of $10,413. The ratio of child: adult WTP is approximately 1 by both gender and age category. The vaccine intervention had the largest amount of $0 WTP and protest responses (52% and 58% respectively). 93% of the participants were able to describe (teach-back) the vaccine effectiveness using their own family as an example.
CONCLUSION: Our study provides empirical evidence on how to better generate CV surveys to produce more robust WTP estimates.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Bangladesh; contingent valuation; dengue; economic burden; stated preference methods; vaccine-preventable diseases; value of statistical life (VSL)

Year:  2021        PMID: 33508753     DOI: 10.1016/j.vhri.2020.10.004

Source DB:  PubMed          Journal:  Value Health Reg Issues        ISSN: 2212-1099


  3 in total

1.  Scope Issue in Contingent Valuation Studies of the COVID-19 Vaccine: The Case of China.

Authors:  Jianhong Xiao; Yihui Wu; Min Wang; Zegang Ma
Journal:  Appl Health Econ Health Policy       Date:  2022-01-10       Impact factor: 3.686

2.  Value of statistical life year in extreme poverty: a randomized experiment of measurement methods in rural Burkina Faso.

Authors:  Stefan T Trautmann; Yilong Xu; Christian König-Kersting; Bryan N Patenaude; Guy Harling; Ali Sié; Till Bärnighausen
Journal:  Popul Health Metr       Date:  2021-11-17

3.  Modeling the potential economic benefits of an oral SARS-CoV-2 vaccine during an outbreak of COVID-19.

Authors:  Bryan Patenaude; Jeromie Ballreich
Journal:  BMC Public Health       Date:  2022-09-22       Impact factor: 4.135

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.